Eli Lilly gets FDA’s speedy review for obesity drug
Eli Lilly and Co (LLY.N) said on Thursday the U.S. Food and Drug Administration (FDA) had agreed to
Eli Lilly and Co (LLY.N) said on Thursday the U.S. Food and Drug Administration (FDA) had agreed to